Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

MJN complies with NAD

This article was originally published in The Tan Sheet

Executive Summary

Mead Johnson Nutritionals says advertising for its Enfamil LIPIL infant formula currently complies with National Advertising Division recommendations, although an oversight initially made it noncompliant. Following a challenge by Abbott Nutrition and three compliance reviews, MJN continued to defy NAD's decision, leaving the self-regulatory forum "no choice but to refer this matter" to the Federal Trade Commission, NAD says Feb. 24. Abbott challenged the claim that MJN's product "is the only infant formula shown in independent clinical studies to improve baby's brain and eye development." An MJN spokeswoman says Feb. 26 the Evansville, Ind.-based firm attempted to comply with NAD's decision, despite disagreeing with aspects of it, but a single coupon with the contested claim "escaped our scrutiny and inadvertently was continued." The coupon has been discontinued, marking full compliance with NAD's decision, the spokeswoman says
Advertisement

Related Content

Mead Johnson Drops Triple Health Guard Formula Exclusivity Claim - NAD

Topics

Advertisement
UsernamePublicRestriction

Register

PS102661

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel